264 related articles for article (PubMed ID: 31760549)
1. Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals.
Olofsson JK; Larsson M; Roa C; Wilson DA; Jonsson Laukka E
Behav Genet; 2020 Jan; 50(1):3-13. PubMed ID: 31760549
[TBL] [Abstract][Full Text] [Related]
2. Both odor identification and ApoE-ε4 contribute to normative cognitive aging.
Finkel D; Reynolds CA; Larsson M; Gatz M; Pedersen NL
Psychol Aging; 2011 Dec; 26(4):872-83. PubMed ID: 21517181
[TBL] [Abstract][Full Text] [Related]
3. Association of
GoodSmith MS; Wroblewski KE; Schumm LP; McClintock MK; Pinto JM
Neurology; 2023 Sep; 101(13):e1341-e1350. PubMed ID: 37495381
[TBL] [Abstract][Full Text] [Related]
4. The effect of the apolipoprotein E ε4 allele and olfactory function on odor identification networks.
Frank C; Albertazzi A; Murphy C
Brain Behav; 2024 May; 14(5):e3524. PubMed ID: 38702902
[TBL] [Abstract][Full Text] [Related]
5. Effect of Worry Level on Recall Memory for Odors in ApoE-ε4 Carriers and Non-Carriers.
Bower ES; Szajer J; Murphy C
J Int Neuropsychol Soc; 2019 May; 25(5):546-556. PubMed ID: 30987686
[TBL] [Abstract][Full Text] [Related]
6. Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-epsilon4.
Olofsson JK; Rönnlund M; Nordin S; Nyberg L; Nilsson LG; Larsson M
Behav Genet; 2009 Sep; 39(5):496-503. PubMed ID: 19633944
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
8. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
9. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
10. Rapid olfactory decline during aging predicts dementia and GMV loss in AD brain regions.
Pacyna RR; Han SD; Wroblewski KE; McClintock MK; Pinto JM
Alzheimers Dement; 2023 Apr; 19(4):1479-1490. PubMed ID: 35899859
[TBL] [Abstract][Full Text] [Related]
11. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
12. Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.
Reijs BLR; Ramakers IHGB; Elias-Sonnenschein L; Teunissen CE; Koel-Simmelink M; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Johannsen P; Vanderstichele H; Verhey F; Devanand DP; Visser PJ
J Alzheimers Dis; 2017; 60(3):1025-1034. PubMed ID: 28984603
[TBL] [Abstract][Full Text] [Related]
13. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
[TBL] [Abstract][Full Text] [Related]
14. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
16. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.
Dhilla Albers A; Asafu-Adjei J; Delaney MK; Kelly KE; Gomez-Isla T; Blacker D; Johnson KA; Sperling RA; Hyman BT; Betensky RA; Hastings L; Albers MW
Ann Neurol; 2016 Dec; 80(6):846-857. PubMed ID: 27696605
[TBL] [Abstract][Full Text] [Related]
17. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
18. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
20. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.
Mayeux R; Small SA; Tang M; Tycko B; Stern Y
Neurobiol Aging; 2001; 22(4):683-9. PubMed ID: 11445269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
